Sarah Ross

I have a broad background in both academic research and oncology drug discovery. My academic career focused on understand the molecular mechanisms that regulate transcription working across a broad area including the oxidative stress response, neuronal specific transcription and TGF-beta signalling. Since joining AstraZeneca in 2007 i have had the opportunity to support a number of projects across different drug platforms (small molecule, antibody and therapeutic antisense) and targets. For the last 4 years I have been focused on delivering targeted therapeutics for KRAS driven cancers leading the bioscience strategy and data delivery for these projects.